Home > News & resources > Page 92

News & resources

Home > News & resources > Page 92

News & resources

Results

No results found. Please try using different filter option(s).

In the media

17 Mar 2022

Covid-19 en Afrique : pour l’étude Anticov, la nouvelle association thérapeutique ne réduit pas le risque d’hospitalisation chez les patients atteints d’une forme légère à modérée

Actualité CD

Scientific articles

7 Mar 2022

A phase II multicenter randomized study to evaluate the safety and efficacy of combining thermotherapy and a short course of miltefosine for the treatment of uncomplicated cutaneous leishmaniasis in the New World

PLOS Neglected Tropical Diseases

Press Releases Translations

28 Feb 2022

L’étude ANTICOV montre que l’association nitazoxanide + ciclésonide ne réduit pas le risque d’hospitalisation chez les patients atteints d’une forme légère à modérée de COVID-19

Press releases

28 Feb 2022

ANTICOV trial finds drug combination nitazoxanide + ciclesonide does not reduce risk of hospitalization in COVID-19 outpatients

In the media

12 Feb 2022

Covid-19 en Afrique : l’essai clinique ANTICOV essaie une nouvelle association thérapeutique pour prévenir les formes légères de la maladie

Actualité CD

In the media

11 Feb 2022

Une nouvelle association thérapeutique destinée à prévenir l’évolution de la Covid-19 vers une forme sévère

Agence Congolaise de Presse

In the media

11 Feb 2022

Lancement d’un essai clinique pour tester le Prozac contre le Covid

Libération

Scientific articles

11 Feb 2022

AmBisome monotherapy and combination AmBisome – miltefosine therapy for the treatment of visceral leishmaniasis in patients co-infected with HIV in India: A randomised open label, parallel arm, phase III trial

Clinical Infectious Diseases

Press Releases Translations

10 Feb 2022

ANTICOV: Klinische Studie zu COVID-19 in ressourcenschwachen Gebieten erprobt neue Kombinationstherapie aus Fluoxetin und Budesonid

Press releases

10 Feb 2022

ANTICOV: clinical trial for COVID-19 in low-resource settings to test a new combination treatment

Press Releases Translations

10 Feb 2022

ANTICOV : L’essai clinique COVID-19 dans les pays à revenu faible et intermédiaire teste une nouvelle association thérapeutique, fluoxétine et budésonide

In the media

10 Dec 2021

11 clinical trials that will shape medicine in 2022

Nature Medicine

Scientific articles

8 Nov 2021

Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study

PLOS Neglected Tropical Diseases

Publications

31 Oct 2021

LEAP Newsletter

Videos

21 Oct 2021

The ANTICOV clinical trial in Guinea

Publications

21 Oct 2021

InfoLEISH 5^th edition

Loading...

Events

Loading...

Stay connected

Get our latest news, personal stories, research articles, and job opportunities.

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

Get in touch

Support us

Work with us